Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.91 Analyst target: $6.00 Upside: 106.19%
bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer. The company is headquartered in San Antonio, Texas.
See the full interactive analysis & chart →Informational only — not investment advice.